Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N05 PSYCHOLEPTICS
N05C HYPNOTICS AND SEDATIVES
N05CH Melatonin receptor agonists
N05CH03 Tasimelteon
D09388 Tasimelteon (USAN/INN) <US>
USP drug classification [BR:br08302]
Sleep Disorder Agents
Sleep Promoting Agents
Tasimelteon
D09388 Tasimelteon (USAN/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01589 Melatonin receptor agonist
D09388 Tasimelteon
Metabolizing enzyme substrate
DG01892 CYP1A2 substrate
D09388 Tasimelteon
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
D09388 Tasimelteon
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Melatonin
MTNR1
D09388 Tasimelteon (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09388
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D09388
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09388
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D09388
Other DBs
CAS:
609799-22-6
PubChem:
96026068
ChEBI:
79042
LigandBox:
D09388
KCF data
ATOM 18
1 C8y C 25.4100 -19.6700
2 C8y C 25.4100 -21.0700
3 C8x C 26.6000 -21.7700
4 C8x C 27.8600 -21.0700
5 C8x C 27.8600 -19.6700
6 C8y C 26.6000 -18.9700
7 C1x C 24.0800 -19.2500
8 C1x C 23.2400 -20.3700
9 O2x O 24.0800 -21.4900
10 C1y C 26.6000 -17.5700
11 C1x C 25.9000 -16.3800
12 C1y C 27.3000 -16.3800
13 C1b C 28.5153 -15.6849
14 N1b N 29.7037 -16.3777
15 C5a C 30.9001 -15.6935
16 C1b C 32.0813 -16.3819
17 O5a O 30.9001 -14.2935
18 C1a C 33.2812 -15.6955
BOND 20
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 1 7 1
8 7 8 1
9 8 9 1
10 2 9 1
11 10 6 1 #Down
12 11 12 1
13 11 10 1
14 12 10 1
15 12 13 1 #Up
16 13 14 1
17 14 15 1
18 15 16 1
19 15 17 2
20 16 18 1